↓ Skip to main content

Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia

Overview of attention for article published in Leukemia & Lymphoma, April 2014
Altmetric Badge

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia
Published in
Leukemia & Lymphoma, April 2014
DOI 10.3109/10428194.2014.893306
Pubmed ID
Authors

Stephen P. Mulligan, Karin Karlsson, Mats Strömberg, Viggo Jønsson, Devinder Gill, Jens Hammerström, Mark Hertzberg, Roger McLennan, Bertil Uggla, John Norman, Jonas Wallvik, Gunnel Sundström, Hemming Johansson, Yvonne Brandberg, Jan Liliemark, Gunnar Juliusson, for the Scandinavian and Australasian Leukaemia Lymphoma Groups

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
United States 1 3%
Unknown 29 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 19%
Other 4 13%
Student > Doctoral Student 4 13%
Student > Ph. D. Student 3 10%
Student > Bachelor 2 6%
Other 6 19%
Unknown 6 19%
Readers by discipline Count As %
Medicine and Dentistry 13 42%
Nursing and Health Professions 3 10%
Agricultural and Biological Sciences 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 5 16%
Unknown 5 16%